English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Plus monthly

Global: Zendy Tools annual

Global: Zendy Tools monthly

Global: Zendy Free Plan

Non-infectious diseases, including hypercholesterolemia, are now ranked top 10 in Indonesia. Statins are inhibitors of HMG-CoA reductase, an enzyme for biosynthesis of cholesterol in the liver. Statins have been proven to reduce the risk of death due to CHD and mortality from various reasons. The objective of the study is to know the utilization of statins in peripheral area of Indonesia. This retrospective study on utilization of statins prescribed for hypercholesterolemia was taken from medical record year of 2014-2015 of a District Hospital – Dr. Haulussy, Ambon, and Maluku. We collected demographic data, pre- and treated concentrations of total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), and triglyceride (TG), types and dosages of statins or other lipid-lowering medications given. Student t-test using was performed to check statistical differences for all cholesterol and TG differences prior to therapy versus during treatment. Eighty three respondents consisted of 26 men (31.3%) and 57 women (68.7%) with mean age 60 ± 11 years old. The pre-treatment/ post-treatment values (mg/dL) of TC: 245.22 ± 51.40/224.97 ± 98.79 (p=0.004); LDL-C: 166.07 ± 45.36/146.00 ± 41.07; HDL-C: 54.52 ± 37.95/43.00 ± 0.00; and TG: 177.36 ± 103.25/121.00 ± 52.87, respectively. Seventy-nine patients (95.2%) were treated with statins. The dosage given were 10 mg (n=19, 22.9%), 20 mg (n= 63, 75.9%), and 40 mg (n=1, 1.2%). Twenty-eight patients (33.7%) had no posttreatment data of cholesterol, and 31 out of 55 patients (56%) were responders. All cholesterol levels were decreased, but responder rate was only 56%. Therefore, dosage adjustment and prerequisite cholesterol level during and post-treatment measurement should be made regularly.

Utilization of Statins, an HMG-CoA reductase inhibitors, in Ambon District Hospital, Maluku: a retrospective study